The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Regulatory News (ASHM)

Share Price Information for Ashmore (ASHM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 198.00
Bid: 197.80
Ask: 198.20
Change: -1.20 (-0.60%)
Spread: 0.40 (0.202%)
Open: 198.00
High: 199.60
Low: 196.50
Prev. Close: 199.20
ASHM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

15 Jan 2024 07:00

RNS Number : 6032Z
Ashmore Group PLC
15 January 2024
 

Ashmore Group plc15 January 2024

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2023.

Assets under management

Theme

Actual30 September 2023

(US$ billion)

Estimated31 December 2023

(US$ billion)

Movementpre reclassification1

 (%)

- External debt

8.9

9.5

+7%

- Local currency

18.4

18.8

+2%

- Corporate debt1

5.5

5.2

+2%

- Blended debt1

11.3

12.4

+6%

Fixed income

44.1

45.9

+4%

Equities

6.0

6.5

+8%

Alternatives

1.6

1.6

-

Total

51.7

54.0

+4%

 

Assets under management increased by US$2.3 billion over the period, comprising positive investment performance of US$3.9 billion and net outflows of US$1.6 billion.

The Group's net outflows reduced from prior quarters as, while there continues to be some risk aversion among certain investors, clients responded to the improving global macro environment. Equities delivered a net inflow and, within the fixed income themes, the outflows were broadly spread with no significant patterns.

The Fed's signalling of the end of its rate hiking cycle and continued economic stability in many emerging countries delivered strong performance across Emerging Markets over the three months. Fixed income indices rose by 6% to 9% and equities increased by 8%, and the majority of Ashmore's strategies outperformed over the quarter. Ashmore's longer-term relative performance (over one, three and five years) remains consistent.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging Markets delivered good returns and outperformed most developed world indices in 2023 due to superior economic growth, effective monetary policies and the benefits of a weaker US dollar as the Fed reaches the end of its tightening cycle. These factors, along with attractive absolute and relative valuations, will support Emerging Markets asset prices in 2024, leading to outperformance and higher allocations from investors who currently have significantly underweight allocations to Emerging Markets. Ashmore continues to deliver outperformance for clients across a broad range of strategies, and activity levels have begun to reflect the improving outlook for the global macro environment."

 

 

Notes

 

1. During the quarter, assets totalling US$0.4 billion were reclassified from corporate debt to blended debt as a result of changes to benchmarks. The quarter-on-quarter % movements and the commentary on flows exclude the effects of this reclassification. Including the reclassification, corporate debt AuM decreased by 5% and blended debt AuM increased by 10% over the period.

Local currency AuM includes US$6.3 billion of AuM managed in overlay/liquidity strategies (30 September 2023: US$6.6 billion).

For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.2748 at 31 December 2023 (30 June 2023: 1.2714; 31 December 2022: 1.2029). For the translation of US dollar management fees, the average GBP:USD exchange rate achieved for the first half of the financial year was 1.2572 (H1 2022: 1.1795).

Ashmore will announce its interim results in respect of the six months ending 31 December 2023 on 7 February 2024.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278 ir@ashmoregroup.com

FTI ConsultingNeil Doyle +44 (0)7771 978 220Kit Dunford +44 (0)7717 417 038 ashmore@fticonsulting.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFDLAIFLIS
Date   Source Headline
19th Jun 20206:07 pmRNSDirector/PDMR Shareholding
19th Jun 20206:04 pmRNSHolding(s) in Company
27th Apr 20203:33 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:44 pmRNS2019 AGM voting result update statement
1st Apr 20209:51 amRNSDirector/PDMR Shareholding
16th Mar 20203:29 pmRNSHolding(s) in Company
13th Mar 20206:21 pmRNSDirector/PDMR Shareholding
7th Feb 20204:50 pmRNSDirector/PDMR Shareholding
7th Feb 20204:49 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSHalf-year Report
15th Jan 20207:00 amRNSTrading Statement
10th Dec 20199:16 amRNSDirector/PDMR Shareholding
9th Dec 20192:08 pmRNSDirector/PDMR Shareholding
11th Nov 201912:17 pmRNSDirector/PDMR Shareholding
21st Oct 201911:42 amRNSDirector Declaration
18th Oct 20193:32 pmRNSResult of AGM
16th Oct 20191:08 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSTrading Statement
30th Sep 20195:38 pmRNSDirector/PDMR Shareholding
30th Sep 20195:33 pmRNSDirector/PDMR Shareholding
18th Sep 201912:04 pmRNSDirector/PDMR Shareholding
18th Sep 201912:01 pmRNSDirector/PDMR Shareholding
16th Sep 20192:07 pmRNS2019 Annual Report and Notice of AGM
6th Sep 20197:00 amRNSFinal Results
12th Jul 20197:00 amRNSTrading Statement
18th Apr 20195:08 pmRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSTrading Statement
5th Apr 20198:57 amRNSDirector/PDMR Shareholding
3rd Apr 20194:37 pmRNSDirector/PDMR Shareholding
3rd Apr 20194:30 pmRNSHolding(s) in Company
14th Mar 20194:50 pmRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSHalf-year Report
15th Jan 20197:00 amRNSTrading Statement
10th Dec 20182:14 pmRNSDirector/PDMR Shareholding
19th Oct 20185:08 pmRNSResult of AGM
12th Oct 20187:00 amRNSTrading Statement
1st Oct 20188:13 amRNSTotal Voting Rights
18th Sep 20186:04 pmRNSDirector/PDMR Shareholding
18th Sep 20186:00 pmRNSDirector/PDMR Shareholding
13th Sep 20184:16 pmRNSHolding(s) in Company
13th Sep 20184:11 pmRNSNotice of AGM
11th Sep 20185:19 pmRNSHolding(s) in Company
11th Sep 20185:04 pmRNSTreasury Shares
7th Sep 20187:00 amRNSFinal Results
6th Sep 20181:41 pmRNSHolding(s) in Company
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.